LEADER 04387nam 2200661 450 001 9910797580803321 005 20230614221656.0 010 $a0-309-31725-8 010 $a0-309-31723-1 035 $a(CKB)3710000000465917 035 $a(EBL)3439864 035 $a(SSID)ssj0001600915 035 $a(PQKBManifestationID)16308107 035 $a(PQKBTitleCode)TC0001600915 035 $a(PQKBWorkID)14893615 035 $a(PQKB)11039149 035 $a(MiAaPQ)EBC3439864 035 $a(Au-PeEL)EBL3439864 035 $a(CaPaEBR)ebr11091773 035 $a(OCoLC)915981814 035 $a(EXLCZ)993710000000465917 100 $a20150904h20152015 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAssessing the use of agent-based models for tobacco regulation /$fCommittee on Assessment of Agent-Based Models to Inform Tobacco Product Regulation, Board on Population Health and Public Health Practice, Robert Wallace, Amy Geller, and V. Ayano Ogawa, Editors, Institute of Medicine of the National Academies 210 1$aWashington, District of Columbia :$cThe National Academies Press,$d[2015] 210 4$dİ2015 215 $a1 online resource (280 p.) 300 $aDescription based upon print version of record. 311 $a0-309-31722-3 320 $aIncludes bibliographical references and index. 327 $aFront Matter; Reviewers; Contents; Acronyms and Abbreviations; Preface; Summary; 1 Introduction; 2 Tobacco Control Landscape; 3 Building Effective Models to Guide Policy Decision Making; 4 An Evaluation Framework for Policy-Relevant Agent-Based Models; 5 Review of the Social Network Analysis for Policy on Directed Graph Networks Model; 6 Data and Implementation Needs for Computational Modeling for Tobacco Control; Appendix A: Considerations and Best Practices in Agent-Based Modeling to Inform Policy--Ross A. Hammond; Appendix B: Agent-Based Models for Policy Analysis--Lawrence Blume 327 $aAppendix C: Assessing Agent-Based Models for Regulatory Applications: Lessons from Energy Analysis--Alan H. Sanstad Appendix D: Committee Meeting Agendas; Appendix E: Committee Biographical Sketches; Index 330 $a"Tobacco consumption continues to be the leading cause of preventable disease and death in the United States. The Food and Drug Administration (FDA) regulates the manufacture, distribution, and marketing of tobacco products - specifically cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco - to protect public health and reduce tobacco use in the United States. Given the strong social component inherent to tobacco use onset, cessation, and relapse, and given the heterogeneity of those social interactions, agent-based models have the potential to be an essential tool in assessing the effects of policies to control tobacco. Assessing the Use of Agent-Based Models for Tobacco Regulation describes the complex tobacco environment; discusses the usefulness of agent-based models to inform tobacco policy and regulation; presents an evaluation framework for policy-relevant agent-based models; examines the role and type of data needed to develop agent-based models for tobacco regulation; provides an assessment of the agent-based model developed for FDA; and offers strategies for using agent-based models to inform decision making in the future."--Publisher's description. 606 $aSmoking$xHealth aspects 606 $aSmoking cessation 606 $aTobacco use$xPrevention 606 $aTobacco use$xHealth aspects$xResearch$zUnited States 615 0$aSmoking$xHealth aspects. 615 0$aSmoking cessation. 615 0$aTobacco use$xPrevention. 615 0$aTobacco use$xHealth aspects$xResearch 676 $a362.2960973 702 $aWallace$b Robert 702 $aGeller$b Amy$g(Amy B.), 702 $aOgawa$b V. Ayano 712 02$aInstitute of Medicine (U.S.).$bCommittee on Assessment of Agent-Based Models to Inform Tobacco Product Regulation, 712 02$aInstitute of Medicine (U.S.).$bBoard on Population Health and Public Health Practice, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797580803321 996 $aAssessing the use of agent-based models for tobacco regulation$93860923 997 $aUNINA